Africa: Rwanda Launches Africa's First Trial of Long-Acting Malaria Prevention Injection
- Words
- 41
- Chars
- 280
- AI summary
- Yes
Full story
Rwanda has started the first clinical trial in Africa for a long-acting malaria prevention injection. This injectable drug aims to change how the disease is prevented. The trial comes as climate change and drug resistance threaten current efforts. The illness is spread by mosquitoes.
[Capital FM] Nairobi -- Rwanda has launched Africa's first clinical trial of a long-acting injectable drug for malaria prevention, marking a potential shift in how the disease is prevented as drug resistance and climate change threaten progress against the mosquito-borne illness.
Open article